Analysts Hate These 12 Stocks in 2019

Posted on Monday, April 22nd, 2019 by MarketBeat Staff

When a single Wall Street analyst downgrades one of your stocks, you might think they are just having a bad day or have an incorrect investment thesis. One downgrade typically won't have a significant impact on the price of one of your stocks, but what if a company was repeatedly downgraded by analysts over the last 30, 60 or 90 days? You would know something is seriously wrong.

Today, we are inviting you to take a free exclusive look at our up-to-the-minute list of 12 "Most Downgraded" stocks. These are true strong sell stocks. Analysts are abandoning them in droves and issuing rare downgrades and sell ratings. If any of these stocks are lurking around in your portfolio, seriously consider whether or not they still belong in your portfolio. .

#1 - Biogen (NASDAQ:BIIB)

Number of Downgrades: 24 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.2
Ratings Breakdown: 7 Buy Ratings, 22 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $295.0442 (30.3% Upside)

Biogen logoBiogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies. Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development. The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Recent Recommendations for Biogen:

  • Biogen Inc (NASDAQ: BIIB) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock. (4/10/2019)
  • Biogen Inc (NASDAQ: BIIB) was downgraded by analysts at TheStreet from a "b-" rating to a "c+" rating. (4/4/2019)
  • Biogen Inc (NASDAQ: BIIB) had its "hold" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $250.00 price target on the stock. (3/27/2019)
  • Biogen Inc (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada to $236.00. They now have a "sector perform" rating on the stock. (3/25/2019)
  • Biogen Inc (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock, down previously from $363.00. (3/25/2019)
  • Biogen Inc (NASDAQ: BIIB) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "underweight" rating. They now have a $210.00 price target on the stock, down previously from $401.00. (3/22/2019)
  • Biogen Inc (NASDAQ: BIIB) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $242.00 price target on the stock, down previously from $395.00. (3/22/2019)
  • Biogen Inc (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $322.00 to $250.00. They now have a "market perform" rating on the stock. (3/22/2019)
  • Biogen Inc (NASDAQ: BIIB) was given a new $236.00 price target on by analysts at Guggenheim. They now have a "hold" rating on the stock. (3/22/2019)
  • Biogen Inc (NASDAQ: BIIB) had its "hold" rating re-affirmed by analysts at Barclays PLC. They now have a $250.00 price target on the stock. (3/22/2019)
#2 - Walgreens Boots Alliance (NASDAQ:WBA)

Number of Downgrades: 18 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.1
Ratings Breakdown: 4 Buy Ratings, 12 Hold Ratings, 3 Sell Ratings.
Consensus Price Target: $66.4444 (21.6% Upside)

Walgreens Boots Alliance logoWalgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services and mail services; and manages in-store clinics. As of August 31, 2018, this segment operated 9,560 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,767 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 618 optical practices, including 167 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. The company has a strategic partnership with Microsoft Corporation. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Recent Recommendations for Walgreens Boots Alliance:

  • Walgreens Boots Alliance Inc (NASDAQ: WBA) is now covered by analysts at Guggenheim. They set a "neutral" rating and a $59.00 price target on the stock. (4/18/2019)
  • Walgreens Boots Alliance Inc (NASDAQ: WBA) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (4/13/2019)
  • Walgreens Boots Alliance Inc (NASDAQ: WBA) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. (4/3/2019)
  • Walgreens Boots Alliance Inc (NASDAQ: WBA) had its price target lowered by analysts at UBS Group AG from $60.00 to $49.00. They now have a "sell" rating on the stock. (4/3/2019)
  • Walgreens Boots Alliance Inc (NASDAQ: WBA) had its price target lowered by analysts at Wells Fargo & Co from $75.00 to $65.00. They now have an "outperform" rating on the stock. (4/3/2019)
  • Walgreens Boots Alliance Inc (NASDAQ: WBA) had its price target lowered by analysts at Citigroup Inc from $76.00 to $60.00. They now have a "neutral" rating on the stock. (4/3/2019)
  • Walgreens Boots Alliance Inc (NASDAQ: WBA) had its price target raised by analysts at SunTrust Banks, Inc. to $58.00. They now have a "hold" rating on the stock. (4/3/2019)
  • Walgreens Boots Alliance Inc (NASDAQ: WBA) had its price target lowered by analysts at Pivotal Research from $70.00 to $60.00. They now have a "hold" rating on the stock. (4/3/2019)
  • Walgreens Boots Alliance Inc (NASDAQ: WBA) was downgraded by analysts at Loop Capital from a "buy" rating to a "hold" rating. They now have a $60.00 price target on the stock, down previously from $77.00. (4/3/2019)
  • Walgreens Boots Alliance Inc (NASDAQ: WBA) had its price target lowered by analysts at Morgan Stanley from $67.00 to $61.00. They now have an "equal weight" rating on the stock. (4/3/2019)
#3 - DowDuPont (NYSE:DWDP)

Number of Downgrades: 17 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.5
Ratings Breakdown: 9 Buy Ratings, 11 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $56.1053 (43.9% Upside)

DowDuPont logoDowDuPont Inc., through its subsidiaries, engages in agriculture, materials science, and specialty products businesses in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company's Agriculture segment produces, and sells hybrid corn seed and soybean seed varieties; sunflowers, wheat, alfalfa, canola, cotton, rice, and sorghum; silage inoculants; and crop protection products that include weed control, disease control, and insect control. Its Performance Materials & Coatings segment manufactures and sells architectural paints and coatings, and industrial coatings; performance monomers and silicones; standalone silicones; and home and personal care solutions. The company's Industrial Intermediates & Infrastructure segment offers ethylene oxides, propylene oxide derivatives, cellulose ethers, redispersible latex powders, and acrylic emulsions; sustainable solutions; and chlorine and caustic soda. Its Packaging & Specialty Plastics segment provides ethylene, and propylene and aromatic products; and polyolefin elastomers and ethylene propylene diene monomer rubbers. The company's Electronics & Imaging segment offers materials and systems for mobile devices, television monitors, personal computers, and electronics. Its Nutrition & Biosciences segment provides specialty ingredients, as well as cellulosic- and alginates-based pharma excipients; and enzymes, biomaterials, biocides, and antimicrobial solutions and process technologies. The company's Transportation & Advanced Polymers segment offers engineering resins, adhesives, lubricants, and parts for transportation, electronics, healthcare, industrial, and consumer end-markets. Its Safety & Construction segment provides engineered products and integrated systems for construction, worker safety, energy, oil and gas, transportation, medical device, and water purification and separation industries. The company was founded in 1897 and is headquartered in Midland, Michigan.

Recent Recommendations for DowDuPont:

  • DowDuPont Inc (NYSE: DWDP) was downgraded by analysts at Royal Bank of Canada from a "top pick" rating to a "sector perform" rating. They now have a $40.00 price target on the stock, down previously from $61.00. (4/16/2019)
  • DowDuPont Inc (NYSE: DWDP) had its price target lowered by analysts at Nomura from $57.00 to $39.00. They now have a "neutral" rating on the stock. (4/11/2019)
  • DowDuPont Inc (NYSE: DWDP) had its price target lowered by analysts at SunTrust Banks, Inc. to $41.00. They now have a "positive" rating on the stock. (4/8/2019)
  • DowDuPont Inc (NYSE: DWDP) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. (4/3/2019)
  • DowDuPont Inc (NYSE: DWDP) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $45.00 price target on the stock. (4/3/2019)
  • DowDuPont Inc (NYSE: DWDP) had its price target lowered by analysts at Morgan Stanley from $70.00 to $43.00. They now have an "overweight" rating on the stock. (4/2/2019)
  • DowDuPont Inc (NYSE: DWDP) had its price target lowered by analysts at BMO Capital Markets from $67.00 to $46.00. They now have an "outperform" rating on the stock. (4/2/2019)
  • DowDuPont Inc (NYSE: DWDP) was downgraded by analysts at Bank of America Corp from a "buy" rating to a "neutral" rating. They now have a $44.00 price target on the stock. (4/2/2019)
  • DowDuPont Inc (NYSE: DWDP) was downgraded by analysts at Citigroup Inc from a "buy" rating to a "neutral" rating. They now have a $40.00 price target on the stock, down previously from $60.00. (4/2/2019)
  • DowDuPont Inc (NYSE: DWDP) is now covered by analysts at Goldman Sachs Group Inc. They set a "neutral" rating and a $42.00 price target on the stock. (3/29/2019)
#4 - The Ultimate Software Group (NASDAQ:ULTI)

Number of Downgrades: 16 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.2
Ratings Breakdown: 6 Buy Ratings, 14 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $314.4883 (-4.8% Upside)

The Ultimate Software Group logoThe Ultimate Software Group, Inc. provides cloud-based human capital management solutions to enterprise companies, mid-market companies, and companies in the strategic market in the United States, Canada, Europe, the Asia Pacific, and internationally. Its UltiPro software solution delivers the functionality businesses need to manage the employee life cycle from recruitment to retirement. The company's UltiPro solution includes feature sets for talent acquisition and onboarding, human resources (HR) service delivery and management, benefits management and online enrollment, payroll, performance management, employee engagement surveying, compensation management with salary planning, budgeting, incentive award planning, succession management, learning management, reporting and analytical decision-making and predictive tools and time capture, scheduling, attendance tracking, and absence accruals; and has role-based features for HR professionals, executives, managers, administrators, and employees. Its UltiPro software solution is delivered through software-as-a-service. The company also provides professional services, and customer support and product maintenance services. It markets its products and services to manufacturing, food services, sports, technology, finance, insurance, retail, real estate, transportation, communications, healthcare, and other services industries primarily through direct sales force. The company was founded in 1990 and is headquartered in Weston, Florida.

Recent Recommendations for The Ultimate Software Group:

  • The Ultimate Software Group, Inc. (NASDAQ: ULTI) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (4/13/2019)
  • The Ultimate Software Group, Inc. (NASDAQ: ULTI) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (4/12/2019)
  • The Ultimate Software Group, Inc. (NASDAQ: ULTI) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (4/3/2019)
  • The Ultimate Software Group, Inc. (NASDAQ: ULTI) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. (4/1/2019)
  • The Ultimate Software Group, Inc. (NASDAQ: ULTI) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating. (3/28/2019)
  • The Ultimate Software Group, Inc. (NASDAQ: ULTI) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. (3/27/2019)
  • The Ultimate Software Group, Inc. (NASDAQ: ULTI) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $331.50 price target on the stock, down previously from $340.00. (3/26/2019)
  • The Ultimate Software Group, Inc. (NASDAQ: ULTI) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. (3/26/2019)
  • The Ultimate Software Group, Inc. (NASDAQ: ULTI) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. (3/20/2019)
  • The Ultimate Software Group, Inc. (NASDAQ: ULTI) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. (3/9/2019)
#5 - Tesla (NASDAQ:TSLA)

Number of Downgrades: 15 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.0
Ratings Breakdown: 13 Buy Ratings, 9 Hold Ratings, 14 Sell Ratings.
Consensus Price Target: $313.4242 (14.7% Upside)

Tesla logoTesla, Inc. designs, develops, manufactures, and sells electric vehicles, and energy generation and storage systems in the United States, China, Netherlands, Norway, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers sedans and sport utility vehicles. It also provides electric vehicle powertrain components and systems to other manufacturers; and services for electric vehicles through its company-owned service centers, Service Plus locations, and Tesla mobile technicians. This segment sells its products through a network of company-owned stores and galleries. The Energy Generation and Storage segment offers energy storage products, such as rechargeable lithium-ion battery systems for use in homes, commercial facilities, and utility grids; designs, manufactures, installs, maintains, leases, and sells solar energy systems to residential and commercial customers; and sell renewable energy to residential and commercial customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was founded in 2003 and is headquartered in Palo Alto, California.

Recent Recommendations for Tesla:

  • Tesla Inc (NASDAQ: TSLA) had its "sell" rating re-affirmed by analysts at Citigroup Inc. (4/18/2019)
  • Tesla Inc (NASDAQ: TSLA) had its price target lowered by analysts at Roth Capital from $270.00 to $240.00. They now have a "neutral" rating on the stock. (4/11/2019)
  • Tesla Inc (NASDAQ: TSLA) was given a new $192.00 price target on by analysts at Barclays PLC. They now have a "sell" rating on the stock. (4/9/2019)
  • Tesla Inc (NASDAQ: TSLA) is now covered by analysts at Nomura. They set a "neutral" rating and a $300.00 price target on the stock. (4/9/2019)
  • Tesla Inc (NASDAQ: TSLA) had its "sell" rating re-affirmed by analysts at UBS Group AG. They now have a $200.00 price target on the stock. (4/8/2019)
  • Tesla Inc (NASDAQ: TSLA) had its price target lowered by analysts at Morgan Stanley from $260.00 to $240.00. They now have an "equal weight" rating on the stock. (4/8/2019)
  • Tesla Inc (NASDAQ: TSLA) was given a new $400.00 price target on by analysts at Jefferies Financial Group Inc. They now have a "buy" rating on the stock. (4/8/2019)
  • Tesla Inc (NASDAQ: TSLA) had its "sell" rating re-affirmed by analysts at Vertical Group. They now have a $54.00 price target on the stock, down previously from $72.00. (4/5/2019)
  • Tesla Inc (NASDAQ: TSLA) was given a new $170.00 price target on by analysts at Cowen Inc. They now have a "sell" rating on the stock. (4/4/2019)
  • Tesla Inc (NASDAQ: TSLA) had its "sell" rating re-affirmed by analysts at Goldman Sachs Group Inc. They now have a $210.00 price target on the stock. (4/4/2019)
#6 - Snc-Lavalin Group (TSE:SNC)

Number of Downgrades: 15 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 2.6
Ratings Breakdown: 5 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: C$47.56 (38.8% Upside)

Snc-Lavalin Group logoSNC-Lavalin Group Inc. provides consulting, design, engineering, construction, and operation and maintenance services worldwide. It operates through Mining & Metallurgy; Oil & Gas; Nuclear; Clean Power; Infrastructure; Engineering, Design and Project Management; and Capital segments. The company offers solutions for projects in the aluminum, gold, copper, iron ore, nickel, fertilizer, sulphur, and other projects, as well as commodities related to rechargeable batteries for cars, mobile phones, and other electronic devices. It also undertakes oil and gas projects in the upstream, midstream, downstream, and supporting infrastructure sectors, as well as supports clients in the asset lifecycle from front-end evaluation through decommissioning. In addition, the company supports clients across the nuclear life cycle with the spectrum of services from consultancy, field services, technology services, spare parts, reactor support and decommissioning, and waste management, as well as engineering, procurement, and construction management services. Further, it delivers hydroelectric transmission and distribution projects; and undertakes infrastructure projects in various sectors consisting of mass transit, heavy rail, roads, bridges, airports, ports and harbors, facilities architecture and engineering, industrial, geotechnical engineering, materials testing, and water infrastructure, as well as operations and maintenance projects. Additionally, the company provides engineering, design, and project management services for projects in transportation, infrastructure, aerospace, defense, and security and technology sectors; and invests in various infrastructure assets, such as bridges and highways, mass transit systems, power facilities, energy infrastructure, and water treatment plants. SNC-Lavalin Group Inc. was founded in 1911 and is headquartered in Montreal, Canada.

Recent Recommendations for Snc-Lavalin Group:

  • Snc-Lavalin Group Inc (TSE: SNC) had its "market perform" rating re-affirmed by analysts at Raymond James. They now have a C$40.00 price target on the stock. (4/9/2019)
  • Snc-Lavalin Group Inc (TSE: SNC) had its price target lowered by analysts at National Bank Financial from C$52.00 to C$50.00. They now have an "outperform" rating on the stock. (4/8/2019)
  • Snc-Lavalin Group Inc (TSE: SNC) had its price target lowered by analysts at BMO Capital Markets from C$40.00 to C$38.00. (4/8/2019)
  • Snc-Lavalin Group Inc (TSE: SNC) had its "market perform" rating re-affirmed by analysts at Raymond James. They now have a C$43.00 price target on the stock. (3/27/2019)
  • Snc-Lavalin Group Inc (TSE: SNC) had its price target lowered by analysts at Raymond James from C$45.00 to C$43.00. They now have a "market perform" rating on the stock. (2/26/2019)
  • Snc-Lavalin Group Inc (TSE: SNC) had its price target lowered by analysts at Royal Bank of Canada from C$48.00 to C$44.00. (2/15/2019)
  • Snc-Lavalin Group Inc (TSE: SNC) had its price target lowered by analysts at National Bank Financial from C$54.00 to C$52.00. They now have an "outperform" rating on the stock. (2/12/2019)
  • Snc-Lavalin Group Inc (TSE: SNC) was given a new C$45.00 price target on by analysts at Raymond James. They now have a "market perform" rating on the stock. (2/12/2019)
  • Snc-Lavalin Group Inc (TSE: SNC) had its price target lowered by analysts at TD Securities from C$47.00 to C$45.00. They now have a "buy" rating on the stock. (2/12/2019)
  • Snc-Lavalin Group Inc (TSE: SNC) had its price target lowered by analysts at Canaccord Genuity from C$44.00 to C$43.00. (2/11/2019)
#7 - Evolent Health (NYSE:EVH)

Number of Downgrades: 15 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 11 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $27.15 (105.2% Upside)

Evolent Health logoEvolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Recent Recommendations for Evolent Health:

  • Evolent Health Inc (NYSE: EVH) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (4/19/2019)
  • Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (4/9/2019)
  • Evolent Health Inc (NYSE: EVH) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (4/1/2019)
  • Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (3/26/2019)
  • Evolent Health Inc (NYSE: EVH) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (3/20/2019)
  • Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (3/13/2019)
  • Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (3/7/2019)
  • Evolent Health Inc (NYSE: EVH) had its price target lowered by analysts at KeyCorp from $32.00 to $20.00. They now have an "overweight" rating on the stock. (3/4/2019)
  • Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (2/28/2019)
  • Evolent Health Inc (NYSE: EVH) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. (2/28/2019)
#8 - Kraft Heinz (NASDAQ:KHC)

Number of Downgrades: 15 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.0
Ratings Breakdown: 3 Buy Ratings, 14 Hold Ratings, 4 Sell Ratings.
Consensus Price Target: $42.6441 (29.4% Upside)

Kraft Heinz logoThe Kraft Heinz Company manufactures and markets food and beverage products in the United States, Canada, Europe, and internationally. Its products include condiments and sauces, cheese and dairy products, meals, meats, refreshment beverages, coffee, and other grocery products. The company offers its products under the Kraft, Oscar Mayer, Heinz, Philadelphia, Lunchables, Velveeta, Planters, Maxwell House, Capri Sun, Ore-Ida, Kool-Aid, Jell-O, Cracker Barrel, P'Tit Cheese, Tassimo, Classico, Plasmon, Pudliszki, Honig, HP, Benedicta, ABC, Master, Quero, Golden Circle, Wattie's, Glucon D, and Complan names. It sells its products through its own sales organizations, as well as through independent brokers, agents, and distributors to convenience stores, drug stores, value stores, bakeries, pharmacies, mass merchants, club stores, foodservice distributors and institutions, including hotels, restaurants, hospitals, health care facilities, and certain government agencies, as well as to chain, wholesale, cooperative, and independent grocery accounts. The company was formerly known as H.J. Heinz Holding Corporation and changed its name to The Kraft Heinz Company in July 2015. The Kraft Heinz Company was founded in 1869 and is headquartered in Pittsburgh, Pennsylvania.

Recent Recommendations for Kraft Heinz:

  • Kraft Heinz Co (NASDAQ: KHC) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. (4/5/2019)
  • Kraft Heinz Co (NASDAQ: KHC) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating. They now have a $27.00 price target on the stock. (3/29/2019)
  • Kraft Heinz Co (NASDAQ: KHC) was downgraded by analysts at TheStreet from a "c-" rating to a "d+" rating. (3/13/2019)
  • Kraft Heinz Co (NASDAQ: KHC) had its "underperform" rating re-affirmed by analysts at Credit Suisse Group AG. (3/8/2019)
  • Kraft Heinz Co (NASDAQ: KHC) had its "neutral" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $35.00 price target on the stock. (3/4/2019)
  • Kraft Heinz Co (NASDAQ: KHC) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "market perform" rating. (3/4/2019)
  • Kraft Heinz Co (NASDAQ: KHC) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $35.00 price target on the stock. (3/4/2019)
  • Kraft Heinz Co (NASDAQ: KHC) was upgraded by analysts at Societe Generale from a "sell" rating to a "hold" rating. They now have a $34.00 price target on the stock, down previously from $45.00. (3/1/2019)
  • Kraft Heinz Co (NASDAQ: KHC) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating. They now have a $34.35 price target on the stock. (2/26/2019)
  • Kraft Heinz Co (NASDAQ: KHC) had its price target lowered by analysts at BMO Capital Markets from $61.00 to $40.00. They now have a "market perform" rating on the stock. (2/25/2019)
#9 - J B Hunt Transport Services (NASDAQ:JBHT)

Number of Downgrades: 14 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.3
Ratings Breakdown: 5 Buy Ratings, 9 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $115.3758 (18.7% Upside)

J B Hunt Transport Services logoJ.B. Hunt Transport Services, Inc., together with its subsidiaries, provides surface transportation and delivery services in the continental United States, Canada, and Mexico. It operates in four segments: Intermodal (JBI), Dedicated Contract Services (DCS), Integrated Capacity Solutions (ICS), and Truckload (JBT). The JBI segment offers intermodal freight solutions, including origin and destination pickup, and delivery services. It operates 88,739 pieces of company-owned trailing equipment; owns and maintains its own chassis fleet of 81,442 units; and manages a fleet of 5,017 company-owned tractors, 633 independent contractor trucks, and 6,208 company drivers. The DCS segment designs, develops, and executes supply-chain solutions that support various transportation networks. As of December 31, 2018, it operated 9,652 company-owned trucks, 412 customer-owned trucks, and 51 independent contractor trucks, as well as 20,344 owned pieces of trailing equipment and 6,366 customer-owned trailers. The ICS segment offers traditional freight brokerage and transportation logistics solutions; and flatbed, refrigerated, expedited, and less-than-truckload solutions, as well as various dry-van and intermodal solutions. It also provides single-source logistics management for customers that desire to outsource their transportation functions. This segment operates 44 remote sales offices or branches. The JBT segment offers full-load and dry-van freight services by utilizing tractors operating over roads and highways. As of December 31, 2018, it operated 1,139 company-owned tractors. The company also transports or arranges for the transportation of freight, including general merchandise, specialty consumer items, appliances, forest and paper products, food and beverages, building materials, soaps and cosmetics, automotive parts, agricultural products, electronics, and chemicals. J.B. Hunt Transport Services, Inc. was incorporated in 1961 and is headquartered in Lowell, Arkansas.

Recent Recommendations for J B Hunt Transport Services:

  • J B Hunt Transport Services Inc (NASDAQ: JBHT) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (4/18/2019)
  • J B Hunt Transport Services Inc (NASDAQ: JBHT) was downgraded by analysts at Deutsche Bank AG from a "buy" rating to a "sell" rating. They now have a $98.51 price target on the stock. (4/17/2019)
  • J B Hunt Transport Services Inc (NASDAQ: JBHT) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating. (4/17/2019)
  • J B Hunt Transport Services Inc (NASDAQ: JBHT) had its price target lowered by analysts at BMO Capital Markets from $110.00 to $106.00. They now have a "market perform" rating on the stock. (4/16/2019)
  • J B Hunt Transport Services Inc (NASDAQ: JBHT) had its "market perform" rating re-affirmed by analysts at Cowen Inc. They now have a $112.00 price target on the stock, down previously from $122.00. (4/16/2019)
  • J B Hunt Transport Services Inc (NASDAQ: JBHT) had its price target lowered by analysts at Stifel Nicolaus from $115.00 to $107.00. They now have a "hold" rating on the stock. (4/16/2019)
  • J B Hunt Transport Services Inc (NASDAQ: JBHT) had its price target lowered by analysts at Morgan Stanley from $105.00 to $95.00. They now have an "equal weight" rating on the stock. (4/16/2019)
  • J B Hunt Transport Services Inc (NASDAQ: JBHT) had its price target lowered by analysts at Loop Capital to $133.00. They now have a "buy" rating on the stock. (4/16/2019)
  • J B Hunt Transport Services Inc (NASDAQ: JBHT) had its price target lowered by analysts at Barclays PLC from $128.00 to $120.00. They now have an "equal weight" rating on the stock. (4/4/2019)
  • J B Hunt Transport Services Inc (NASDAQ: JBHT) had its price target lowered by analysts at Buckingham Research from $132.00 to $130.00. They now have a "buy" rating on the stock. (4/2/2019)
#10 - Meridian Bioscience (NASDAQ:VIVO)

Number of Downgrades: 14 (in the last 90 days)
Consensus Rating: Sell
Rating Score: 1.3
Ratings Breakdown: 0 Buy Ratings, 1 Hold Ratings, 2 Sell Ratings.
Consensus Price Target: $13.3333 (6.7% Upside)

Meridian Bioscience logoMeridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for various gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms and technologies, including isothermal DNA amplification under the Alethia brand; rapid immunoassays, a single-use immunoassays under the ImmunoCard and ImmunoCard STAT! brand names; enzyme-linked immunoassays under the PREMIER brand; and anodic stripping voltammetry, an electrical chemical sensor platform for quantitative determination under the LeadCare brand. This segment's products are primarily used in the detection of infectious diseases caused by various bacteria, viruses, parasites, and pathogens. Its products consists of gastrointestinal assays, including tests for C. difficile, Enterohemorrhagic E. coli, Campylobacter jejuni, H. pylori, Cryptosporidium, giardia lamblia, and calprotectin; respiratory illness assays, such as tests for Group A Streptococcus, Influenza, M. pneumoniae, Bordetella pertussis, and respiratory syncytial virus; blood chemistry assays; and tests for Group B Streptococcus, Chlamydia trachomatis, Neisseria gonorrhea, Herpes Simplex Virus Type 1 and Type 2, and Malaria. This segment sells its products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. Meridian Bioscience, Inc. was founded in 1976 and is headquartered in Cincinnati, Ohio.

Recent Recommendations for Meridian Bioscience:

  • Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (4/19/2019)
  • Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (4/18/2019)
  • Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. (4/13/2019)
  • Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (4/12/2019)
  • Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (4/6/2019)
  • Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at Canaccord Genuity from a "hold" rating to a "sell" rating. They now have a $11.00 price target on the stock, down previously from $17.00. (4/3/2019)
  • Meridian Bioscience, Inc. (NASDAQ: VIVO) had its price target lowered by analysts at Robert W. Baird from $17.00 to $14.00. They now have a "neutral" rating on the stock. (4/3/2019)
  • Meridian Bioscience, Inc. (NASDAQ: VIVO) had its price target lowered by analysts at Piper Jaffray Companies from $17.00 to $15.00. They now have an "underweight" rating on the stock. (4/2/2019)
  • Meridian Bioscience, Inc. (NASDAQ: VIVO) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. (3/29/2019)
  • Meridian Bioscience, Inc. (NASDAQ: VIVO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. (3/29/2019)
#11 - NVIDIA (NASDAQ:NVDA)

Number of Downgrades: 14 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 2.6
Ratings Breakdown: 25 Buy Ratings, 10 Hold Ratings, 3 Sell Ratings.
Consensus Price Target: $202.0588 (8.5% Upside)

NVIDIA logoNVIDIA Corporation operates as a visual computing company worldwide. It operates in two segments, GPU and Tegra Processor. The GPU segment offers processors, which include GeForce for PC gaming and mainstream PCs; GeForce NOW for cloud-based game-streaming service; Quadro for design professionals working in computer-aided design, video editing, special effects, and other creative applications; Tesla for artificial intelligence (AI) utilizing deep learning, accelerated computing, and general purpose computing; GRID, which provides power of NVIDIA graphics through the cloud and datacenters; DGX for AI scientists, researchers, and developers; and cryptocurrency-specific graphics processing units. The Tegra Processor segment provides processors that are primarily designed to enable branded platforms - DRIVE and SHIELD; DRIVE AGX automotive computers and software stacks, which offer self-driving capabilities; Clara AGX for intelligent medical instruments; SHIELD devices and services designed for mobile-cloud in home entertainment, AI, and gaming applications; and Jetson AGX, an AI computing platform for robotics and other embedded use. The company's products are used in gaming, professional visualization, datacenter, and automotive markets. NVIDIA Corporation sells its products to original equipment manufacturers, original device manufacturers, system builders, add-in board manufacturers, retailers/distributors, Internet and cloud service providers, automotive manufacturers and tier-1 automotive suppliers, mapping companies, start-ups, and other ecosystem participants. The company was founded in 1993 and is headquartered in Santa Clara, California.

Recent Recommendations for NVIDIA:

  • NVIDIA Co. (NASDAQ: NVDA) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. (4/16/2019)
  • NVIDIA Co. (NASDAQ: NVDA) was downgraded by analysts at DZ Bank AG to a "sell" rating. They now have a $170.00 price target on the stock. (4/12/2019)
  • NVIDIA Co. (NASDAQ: NVDA) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. (4/5/2019)
  • NVIDIA Co. (NASDAQ: NVDA) was upgraded by analysts at TheStreet from a "c+" rating to a "b-" rating. (4/4/2019)
  • NVIDIA Co. (NASDAQ: NVDA) is now covered by analysts at Nomura. They set a "neutral" rating and a $147.00 price target on the stock. (4/2/2019)
  • NVIDIA Co. (NASDAQ: NVDA) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. (4/1/2019)
  • NVIDIA Co. (NASDAQ: NVDA) is now covered by analysts at Piper Jaffray Companies. They set an "overweight" rating and a $200.00 price target on the stock. (3/26/2019)
  • NVIDIA Co. (NASDAQ: NVDA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. (3/22/2019)
  • NVIDIA Co. (NASDAQ: NVDA) had its price target raised by analysts at Deutsche Bank AG from $150.00 to $160.00. They now have a "hold" rating on the stock. (3/20/2019)
  • NVIDIA Co. (NASDAQ: NVDA) had its "buy" rating re-affirmed by analysts at Tigress Financial. (3/20/2019)
#12 - Uniti Group (NASDAQ:UNIT)

Number of Downgrades: 14 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 1.5
Ratings Breakdown: 0 Buy Ratings, 4 Hold Ratings, 4 Sell Ratings.
Consensus Price Target: $15.00 (26.7% Upside)

Uniti Group logoUniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of wireless infrastructure solutions for the communications industry. As of December 31, 2018, Uniti owns 5.5 million fiber strand miles, approximately 928 wireless towers, and other communications real estate throughout the United States and Latin America.

Recent Recommendations for Uniti Group:

  • Uniti Group Inc (NASDAQ: UNIT) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. (4/1/2019)
  • Uniti Group Inc (NASDAQ: UNIT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. (4/1/2019)
  • Uniti Group Inc (NASDAQ: UNIT) had its price target lowered by analysts at Deutsche Bank AG from $20.00 to $8.00. They now have a "hold" rating on the stock. (3/22/2019)
  • Uniti Group Inc (NASDAQ: UNIT) had its price target lowered by analysts at Citigroup Inc from $11.00 to $8.00. They now have a "sell" rating on the stock. (3/19/2019)
  • Uniti Group Inc (NASDAQ: UNIT) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. (3/16/2019)
  • Uniti Group Inc (NASDAQ: UNIT) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (3/8/2019)
  • Uniti Group Inc (NASDAQ: UNIT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (3/7/2019)
  • Uniti Group Inc (NASDAQ: UNIT) was downgraded by analysts at Wells Fargo & Co from a "market perform" rating to an "underperform" rating. They now have a $23.00 price target on the stock, up previously from $8.00. (3/5/2019)
  • Uniti Group Inc (NASDAQ: UNIT) had its price target lowered by analysts at Morgan Stanley from $16.00 to $7.00. They now have an "underweight" rating on the stock. (2/26/2019)
  • Uniti Group Inc (NASDAQ: UNIT) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. (2/22/2019)
#13 - GameStop (NYSE:GME)

Number of Downgrades: 14 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 1.8
Ratings Breakdown: 1 Buy Ratings, 4 Hold Ratings, 3 Sell Ratings.
Consensus Price Target: $11.1250 (26.9% Upside)

GameStop logoGameStop Corp. operates as a multichannel video game and consumer electronics retailer in the United States, Canada, Australia, and Europe. The company sells new and pre-owned video game hardware; video game software; pre-owned and value video games; video game accessories, including controllers, gaming headsets, virtual reality products, memory cards, and other add-ons for use with video game hardware and software; and digital products, such as downloadable content, network points cards, prepaid digital and prepaid subscription cards, and digitally downloadable software, as well as collectible products. It also sells collectibles comprising licensed merchandise primarily related to the video game, television, and movie industries, as well as pop culture themes; gaming-related print media, and mobile and consumer electronics; PC entertainment software in various genres comprising sports, action, strategy, adventure/role playing, and simulation; and strategy guides, magazines, and interactive game figures. In addition, the company operates e-commerce sites under the GameStop, EB Games, Micromania, and ThinkGeek brands; and collectibles stores under the Zing Pop Culture and ThinkGeek brand, as well as Game Informer, a video game magazine. Further, it operates 43 Simply Mac branded stores, which sell Apple products, including desktop computers, laptops, tablets and smart phones, and related accessories and other consumer electronic products, as well as warranty and repair services. As of April 2, 2019, the company operated 5,800 stores across 14 countries. The company was formerly known as GSC Holdings Corp. GameStop Corp. was founded in 1994 and is headquartered in Grapevine, Texas.

Recent Recommendations for GameStop:

  • GameStop Corp. (NYSE: GME) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. (4/4/2019)
  • GameStop Corp. (NYSE: GME) had its price target lowered by analysts at Credit Suisse Group AG from $11.00 to $10.00. They now have an "underperform" rating on the stock. (4/3/2019)
  • GameStop Corp. (NYSE: GME) had its price target lowered by analysts at Bank of America Corp from $9.00 to $5.00. They now have an "underperform" rating on the stock. (4/3/2019)
  • GameStop Corp. (NYSE: GME) had its price target lowered by analysts at Wedbush from $15.00 to $12.00. They now have an "outperform" rating on the stock. (4/3/2019)
  • GameStop Corp. (NYSE: GME) had its price target lowered by analysts at Telsey Advisory Group from $11.00 to $10.00. They now have a "market perform" rating on the stock. (4/3/2019)
  • GameStop Corp. (NYSE: GME) had its "buy" rating re-affirmed by analysts at Wedbush. They now have a $15.00 price target on the stock. (3/28/2019)
  • GameStop Corp. (NYSE: GME) was given a new $12.00 price target on by analysts at Jefferies Financial Group Inc. They now have a "hold" rating on the stock. (3/22/2019)
  • GameStop Corp. (NYSE: GME) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (3/12/2019)
  • GameStop Corp. (NYSE: GME) was downgraded by analysts at Bank of America Corp from a "neutral" rating to an "underperform" rating. They now have a $9.00 price target on the stock, down previously from $12.00. (3/8/2019)
  • GameStop Corp. (NYSE: GME) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (2/25/2019)
#14 - TAKE-TWO INTERACTIVE SOFTWARE (NASDAQ:TTWO)

Number of Downgrades: 13 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 2.8
Ratings Breakdown: 17 Buy Ratings, 1 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $133.4968 (47.1% Upside)

TAKE-TWO INTERACTIVE SOFTWARE logoTake-Two Interactive Software, Inc. develops, publishes, and markets interactive entertainment solutions for consumers worldwide. The company offers its products under the Rockstar Games and 2K labels, as well as under Private Division and Social Point labels. It develops and publishes action/adventure products under the Grand Theft Auto, Max Payne, Midnight Club, and Red Dead names through developing sequels; and offers downloadable episodes, content and virtual currency, and releasing titles for smartphones and tablets. The company also develops brands in other genres, including the L.A. Noire, Bully, and Manhunt franchises. In addition, the company publishes various entertainment properties across platforms and a range of genres, including shooter, action, role-playing, strategy, sports, and family/casual entertainment under the BioShock, Mafia, Sid Meier's Civilization, XCOM series, Borderlands, and Evolve. Further, it publishes sports simulation titles, including NBA 2K series, a basketball video game; and the WWE 2K professional wrestling series. Additionally, the company offers free-to-play mobile games, such as Dragon City and Monster Legends. Its products are designed for console gaming systems, such as Sony's PlayStation 3 and PlayStation 4, and Microsoft's Xbox 360 and Xbox One; and personal computers comprising smartphones and tablets. The company provides its products through physical retail, digital download, online platforms, and cloud streaming services. Take-Two Interactive Software, Inc. was founded in 1993 and is headquartered in New York, New York.

Recent Recommendations for TAKE-TWO INTERACTIVE SOFTWARE:

  • TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ: TTWO) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (4/18/2019)
  • TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ: TTWO) had its price target lowered by analysts at Morgan Stanley from $130.00 to $120.00. They now have an "overweight" rating on the stock. (4/17/2019)
  • TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ: TTWO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (4/11/2019)
  • TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ: TTWO) was given a new $110.00 price target on by analysts at Stephens. They now have a "buy" rating on the stock. (3/26/2019)
  • TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ: TTWO) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. (3/9/2019)
  • TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ: TTWO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (3/4/2019)
  • TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ: TTWO) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (2/23/2019)
  • TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ: TTWO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $104.00 price target on the stock. (2/15/2019)
  • TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ: TTWO) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. (2/14/2019)
  • TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ: TTWO) was downgraded by analysts at BMO Capital Markets from a "market perform" rating to an "underperform" rating. They now have a $93.44 price target on the stock, up previously from $90.50. (2/12/2019)
#15 - Synaptics (NASDAQ:SYNA)

Number of Downgrades: 13 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.4
Ratings Breakdown: 4 Buy Ratings, 6 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $48.70 (27.7% Upside)

Synaptics logoSynaptics Incorporated develops, markets, and sells intuitive human interface solutions for electronic devices and products worldwide. The company offers its products and solutions for smartphones, tablets, and touchscreen applications, as well as mobile, handheld, wireless, and entertainment devices; notebook applications; and other personal computer (PC) product applications. Its products include ClearPad, which enables users to interact directly with the display on mobile smartphones, tablets, and automobiles; ClearView products that provide advanced image processing and low power technology for entry-level smartphones; TouchView products, which integrate touch and display technologies to deliver performance and simplified design; and Natural ID, a fingerprint ID product that is used in smartphones, tablets, notebook PCs, PC peripherals, and other applications. The company also provides TouchPad, a touch-sensitive pad that senses the position and movement of one or more fingers on its surface; SecurePad that integrates fingerprint sensor directly into the TouchPad area; ClickPad that offers a clickable mechanical design to the TouchPad solution; ForcePad, a thinner version of its ClickPad; AudioSmart personal voice and audio solutions; VideoSmart single-chip 4K UHD media processors for TVs, set-top boxes, and over-the-top streaming devices; and ImagingSmart solutions. In addition, it offers TouchPad with a pointing stick in a single notebook computer enabling users to select their interface of choice; TouchStyk, a self-contained pointing stick module; and TouchButtons, which provides capacitive buttons and scrolling controls, as well as display interface products. The company sells its products through direct sales, outside sales representatives, distributors, and resellers. It serves smartphone, tablet, and PC original equipment manufacturers; and consumer electronics manufacturers. The company was founded in 1986 and is headquartered in San Jose, California.

Recent Recommendations for Synaptics:

  • Synaptics, Incorporated (NASDAQ: SYNA) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (4/11/2019)
  • Synaptics, Incorporated (NASDAQ: SYNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. (4/10/2019)
  • Synaptics, Incorporated (NASDAQ: SYNA) had its "buy" rating re-affirmed by analysts at Craig Hallum. They now have a $47.00 price target on the stock, down previously from $48.00. (4/8/2019)
  • Synaptics, Incorporated (NASDAQ: SYNA) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. (4/1/2019)
  • Synaptics, Incorporated (NASDAQ: SYNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. (3/30/2019)
  • Synaptics, Incorporated (NASDAQ: SYNA) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. (3/26/2019)
  • Synaptics, Incorporated (NASDAQ: SYNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. (3/22/2019)
  • Synaptics, Incorporated (NASDAQ: SYNA) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. (3/22/2019)
  • Synaptics, Incorporated (NASDAQ: SYNA) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. (3/19/2019)
  • Synaptics, Incorporated (NASDAQ: SYNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $45.00 price target on the stock, down previously from $60.00. (3/19/2019)
#16 - Rio Tinto (NYSE:RIO)

Number of Downgrades: 13 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 1.9
Ratings Breakdown: 3 Buy Ratings, 11 Hold Ratings, 6 Sell Ratings.
Consensus Price Target: $59.4367 (-2.2% Upside)

Rio Tinto logoRio Tinto plc, a mining and metals company, explores for, develops, produces, and processes minerals and metals worldwide. It finds, mines, and processes mineral resources, including aluminum, copper, diamonds, gold, iron ore, thermal and metallurgical coal, and uranium, as well as industrial minerals, such as borates, titanium dioxide, and salt. The company was founded in 1873 and is headquartered in London, the United Kingdom. Rio Tinto plc is a subsidiary of Rio Tinto Group.

Recent Recommendations for Rio Tinto:

  • Rio Tinto plc ADR (NYSE: RIO) was downgraded by analysts at Investec from a "buy" rating to a "hold" rating. (4/17/2019)
  • Rio Tinto plc ADR (NYSE: RIO) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. (4/16/2019)
  • Rio Tinto plc ADR (NYSE: RIO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $71.00 price target on the stock. (4/11/2019)
  • Rio Tinto plc ADR (NYSE: RIO) was downgraded by analysts at BNP Paribas from a "neutral" rating to an "underperform" rating. (4/10/2019)
  • Rio Tinto plc ADR (NYSE: RIO) was downgraded by analysts at Exane BNP Paribas from a "neutral" rating to an "underperform" rating. (4/10/2019)
  • Rio Tinto plc ADR (NYSE: RIO) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. (4/10/2019)
  • Rio Tinto plc ADR (NYSE: RIO) was upgraded by analysts at Vertical Research from a "sell" rating to a "hold" rating. (4/4/2019)
  • Rio Tinto plc ADR (NYSE: RIO) was upgraded by analysts at Vertical Group from a "sell" rating to a "hold" rating. (4/4/2019)
  • Rio Tinto plc ADR (NYSE: RIO) had its "neutral" rating re-affirmed by analysts at UBS Group AG. (3/27/2019)
  • Rio Tinto plc ADR (NYSE: RIO) was downgraded by analysts at Societe Generale from a "hold" rating to a "sell" rating. They now have a $55.23 price target on the stock. (3/7/2019)
#17 - Mobile Mini (NASDAQ:MINI)

Number of Downgrades: 13 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 2.6
Ratings Breakdown: 3 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $47.40 (39.5% Upside)

Mobile Mini logoMobile Mini, Inc. provides portable storage and specialty containment solutions. It operates through three segments: Storage Solutions North America, Storage Solutions United Kingdom, and Tank & Pump Solutions. The company offers various portable storage and office products, including steel storage containers and steel ground level offices serving construction companies, large and small retailers, medical centers, schools, utilities, distributors, the military, hotels, restaurants, entertainment complexes, and households for application in the storage of construction materials and equipment, retail and manufacturing inventory, documents and records, and other goods. It also provides a range of specialty containment equipment, such as steel tanks, stainless steel tank trailers, and pumps and filtration equipment, as well as roll-off, vacuum, and dewatering boxes. In addition, the company offers specialty containment services comprising transportation of containers for waste management; waste management oversight and service; system design that includes assessment of pumping, filtration, and temporary storage needs; and field services to install and connect customer containment equipment. It primarily leases its specialty products for chemical, refinery, oil and natural gas drilling, mining, and environmental service customers. As of February 1, 2018, the company operated a rental fleet of approximately 195,600 storage solution containers and office units; and 12,600 units of tank and pump solutions in the United States. Its network also consisted of 154 locations in the United States, the United Kingdom, and Canada. The company was founded in 1983 and is headquartered in Phoenix, Arizona.

Recent Recommendations for Mobile Mini:

  • Mobile Mini Inc (NASDAQ: MINI) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (4/18/2019)
  • Mobile Mini Inc (NASDAQ: MINI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (4/11/2019)
  • Mobile Mini Inc (NASDAQ: MINI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (4/4/2019)
  • Mobile Mini Inc (NASDAQ: MINI) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (3/29/2019)
  • Mobile Mini Inc (NASDAQ: MINI) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (3/22/2019)
  • Mobile Mini Inc (NASDAQ: MINI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. (3/22/2019)
  • Mobile Mini Inc (NASDAQ: MINI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (3/19/2019)
  • Mobile Mini Inc (NASDAQ: MINI) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (3/12/2019)
  • Mobile Mini Inc (NASDAQ: MINI) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. (3/9/2019)
  • Mobile Mini Inc (NASDAQ: MINI) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (3/5/2019)
#18 - Vanda Pharmaceuticals (NASDAQ:VNDA)

Number of Downgrades: 13 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 2.4
Ratings Breakdown: 5 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $36.00 (116.2% Upside)

Vanda Pharmaceuticals logoVanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The company's marketed products include HETLIOZ (tasimelteon), a product for the treatment of non-24-hour sleep-wake disorders; and Fanapt (iloperidone), a product for the treatment of schizophrenia. Its products also include Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist that is under the clinical development for the treatment of chronic pruritus in atopic dermatitis and gastroparesis; VTR-297, a small molecule histone deacetylase inhibitor, which is in clinical development stage for the treatment of hematologic malignancies; and VQW-765, a Phase II alpha-7 nicotinic acetylcholine receptor partial agonist. In addition, the company is developing cystic fibrosis transmembrane conductance regulator activators and inhibitors. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

Recent Recommendations for Vanda Pharmaceuticals:

  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. (4/18/2019)
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock. (4/18/2019)
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (4/11/2019)
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. (3/29/2019)
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. (3/27/2019)
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (3/27/2019)
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock. (3/22/2019)
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. (3/21/2019)
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (3/12/2019)
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. (3/9/2019)
#19 - Applied Optoelectronics (NASDAQ:AAOI)

Number of Downgrades: 13 (in the last 90 days)
Consensus Rating: Hold
Rating Score: 1.7
Ratings Breakdown: 1 Buy Ratings, 5 Hold Ratings, 4 Sell Ratings.
Consensus Price Target: $20.6667 (64.2% Upside)

Applied Optoelectronics logoApplied Optoelectronics, Inc. designs, manufactures, and sells various fiber-optic networking products worldwide. It offers optical modules, lasers, transmitters and transceivers, and turn-key equipment, as well as headend, node, and distribution equipment. The company sells its products to Internet data center operators, cable television and telecommunications equipment manufacturers, and Internet service providers through its direct and indirect sales channels. Applied Optoelectronics, Inc. was founded in 1997 and is headquartered in Sugar Land, Texas.

Recent Recommendations for Applied Optoelectronics:

  • Applied Optoelectronics Inc (NASDAQ: AAOI) had its "sell" rating re-affirmed by analysts at Rosenblatt Securities. They now have a $10.00 price target on the stock. (4/15/2019)
  • Applied Optoelectronics Inc (NASDAQ: AAOI) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. (4/13/2019)
  • Applied Optoelectronics Inc (NASDAQ: AAOI) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. (4/11/2019)
  • Applied Optoelectronics Inc (NASDAQ: AAOI) had its price target lowered by analysts at Piper Jaffray Companies from $12.00 to $11.00. They now have a "neutral" rating on the stock. (4/9/2019)
  • Applied Optoelectronics Inc (NASDAQ: AAOI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (4/3/2019)
  • Applied Optoelectronics Inc (NASDAQ: AAOI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (3/28/2019)
  • Applied Optoelectronics Inc (NASDAQ: AAOI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (3/21/2019)
  • Applied Optoelectronics Inc (NASDAQ: AAOI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (3/14/2019)
  • Applied Optoelectronics Inc (NASDAQ: AAOI) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. (3/12/2019)
  • Applied Optoelectronics Inc (NASDAQ: AAOI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. (3/5/2019)
#20 - Worldpay (NYSE:WP)

Number of Downgrades: 13 (in the last 90 days)
Consensus Rating: Buy
Rating Score: 2.6
Ratings Breakdown: 16 Buy Ratings, 13 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $110.2564 (-0.9% Upside)

Worldpay logoWorldpay, Inc., through its subsidiary, Worldpay Holding, LLC, provides electronic payment processing services in the United States, Europe, Asia, and Australasia. It operates in two segments, Technology Solutions, Merchant Solutions, and Issuer Solutions. The company offers merchant acquiring and payment processing services, such as authorization and settlement, customer service, chargeback and retrieval processing, and interchange management. It also provides value-added services, such data analytics and information management solutions, foreign currency management, and various funding options; and security solutions, including point-to-point encryption and tokenization at the point of sale and for e-commerce transactions. In addition, the company offers card issuer processing, payment network processing, fraud protection, card production, prepaid program management, automated teller machine driving, portfolio optimization, data analytics, and card program marketing, as well as network gateway and switching services. Further, it provides card and statement production, and collections and inbound/outbound call centers. The company serves merchants and financial institutions comprising regional banks, community banks, credit unions, and regional personal identification number networks through direct sales forces and referral partners. The company was formerly known as Vantiv, Inc. and changed its name to Worldpay, Inc. in January 2018. Worldpay, Inc. was incorporated in 2009 and is headquartered in Cincinnati, Ohio.

Recent Recommendations for Worldpay:

  • Worldpay Inc (NYSE: WP) had its price target raised by analysts at Barclays PLC from $131.00 to $136.00. They now have an "overweight" rating on the stock. (4/10/2019)
  • Worldpay Inc (NYSE: WP) had its price target raised by analysts at Royal Bank of Canada from $110.00 to $143.00. They now have an "outperform" rating on the stock. (4/4/2019)
  • Worldpay Inc (NYSE: WP) had its price target raised by analysts at Craig Hallum from $115.00 to $130.00. They now have a "buy" rating on the stock. (3/25/2019)
  • Worldpay Inc (NYSE: WP) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating. They now have a $107.06 price target on the stock. (3/21/2019)
  • Worldpay Inc (NYSE: WP) was downgraded by analysts at Atlantic Securities from an "overweight" rating to a "neutral" rating. (3/21/2019)
  • Worldpay Inc (NYSE: WP) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $112.00 price target on the stock, up previously from $103.00. (3/20/2019)
  • Worldpay Inc (NYSE: WP) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. (3/19/2019)
  • Worldpay Inc (NYSE: WP) was downgraded by analysts at Buckingham Research from a "buy" rating to a "neutral" rating. They now have a $112.00 price target on the stock, down previously from $115.00. (3/19/2019)
  • Worldpay Inc (NYSE: WP) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $112.00 price target on the stock, up previously from $108.00. (3/19/2019)
  • Worldpay Inc (NYSE: WP) was downgraded by analysts at Cowen Inc from an "outperform" rating to a "market perform" rating. (3/19/2019)




More on MarketBeat
20 Stocks to Sell Now20 Stocks to Sell Now
9 High-Yield Dividend Stocks that Pay Monthly9 High-Yield Dividend Stocks that Pay Monthly
8 Small-Cap Stocks Ripe for Solid Growth in 20198 Small-Cap Stocks Ripe for Solid Growth in 2019
8 Stocks Under $10 Analysts Love8 Stocks Under $10 Analysts Love
Top Fifteen Highest-Rated Dividend CompaniesTop Fifteen Highest-Rated Dividend Companies
15 REITS Analysts Can15 REITS Analysts Can't Stop Recommending
8 Growth Stocks to Sell Now8 Growth Stocks to Sell Now





Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel